Weight-Based Dosing 200 lbs : 300-500 mcg Obese : May require higher doses, supervised Administration Guidelines Injection Method SubQ for best absorption
doi.org/10.1016/S0140-6736(23)01053-X Knerr, P
If CagriSema truly prevents the metabolic slowdown associated with weight loss, as the preclinical data suggests, it could produce more durable outcomes with less weight regain after treatment completion
This provides a baseline to track changes during hormone-based peptide therapy and ensures fat loss occurs while preserving muscle tissue
But Save the Microbes, Too
By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility [3]